Ignite Creation Date:
2025-12-24 @ 12:54 PM
Ignite Modification Date:
2026-03-12 @ 2:49 PM
Study NCT ID:
NCT05917561
Status:
RECRUITING
Last Update Posted:
2023-12-22
First Post:
2023-05-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo
Sponsor:
University Hospital, Bordeaux
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CHUBX 2022/03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |